Tiziana Life Sciences PLC - London-registered biotechnology company - Plans to effect the demerger of StemPrintER from the group continuing to be progressed. Issued 2.3 million ordinary shares under the company's ATM sales agreement announced in April to meet sales of a total of 468,689 American depositary shares under the ATM sales agreement, totalling gross proceeds of USD2.8 million in the month of June.
Current stock price: 105.00 pence
Year-to-date change: up more than 100%; 41.00 pence on January 2
By Tapan Panchal; tapanpanchal@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.